Evaluate SAGE-547 in Female Patients With Severe Postpartum Depression
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label proof-of-concept study designed to evaluate the safety, tolerability,
PK, and efficacy of SAGE-547 Injection in adult female patients diagnosed with severe
postpartum depression (PPD).